Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial
Authors:
- 1 July 2024
- journal article
- research article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 20 (14) , e898-e904
Abstract
The WOEST-3 trial compares a 30-day dual antiplatelet therapy strategy with guideline-directed therapy in atrial fibrillation patients undergoing percutaneous coronary intervention.Keywords
This publication has 27 references indexed in Scilit:
- Commentary: Temporarily omitting oral anticoagulants early after stenting for acute coronary syndromes patients with atrial fibrillationInternational Journal of Cardiology, 2020
- Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trialsInternational Journal of Cardiology, 2020
- Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trialThe Lancet, 2019
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial FibrillationNew England Journal of Medicine, 2017
- Perioperative Bridging Anticoagulation in Patients with Atrial FibrillationNew England Journal of Medicine, 2015
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trialThe Lancet, 2013
- Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial FibrillationArchives of internal medicine (1960), 2010
- Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry dataThe Lancet, 2009
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialThe Lancet, 2006